| Particulars |
| Company Name |
Suven Life Sciences Ltd |
Year End |
202403 |
| Full Year |
| Equity (Rs Cr.) |
21.81 |
B.V. Rs |
37.90 |
| Sales Rs Cr. |
11.69 |
NP Rs Cr. |
-20.01 |
| NP Var% |
28.00 |
Div% |
0.00 |
| CPS Rs |
-0.60 |
EPS Rs |
-0.90 |
| Traded Value(Rs Lakhs) |
101.34 |
52 Week High |
169.00 |
| 52 Week Low |
83.00 |
Price BSE |
142.00 |
| Price NSE |
142.00 |
Market Capital(Rs Cr.) |
3,099.92 |
| P/C Ratio |
-229.20 |
P/E Ratio |
-154.70 |
| Price Vs.BV |
3.75 |
|
| Latest Quarter |
| Year End |
202412 |
Sales Rs Cr. |
1.61 |
| NP Rs Cr. |
-13.27 |
NP Var % |
-178.00 |
| Trailing Twelve Months |
| Year End |
202412 |
Sales |
8.41 |
| OPM |
-472.86 |
NP |
-26.63 |
| NP Var% |
-140.80 |
EPS |
0.00 |
| PE |
0.00 |
|
|